首页    期刊浏览 2024年12月12日 星期四
登录注册

文章基本信息

  • 标题:Gsα-selective G protein antagonists
  • 本地全文:下载
  • 作者:M. Hohenegger ; M. Waldhoer ; W. Beindl
  • 期刊名称:Proceedings of the National Academy of Sciences
  • 印刷版ISSN:0027-8424
  • 电子版ISSN:1091-6490
  • 出版年度:1998
  • 卷号:95
  • 期号:1
  • 页码:346-351
  • DOI:10.1073/pnas.95.1.346
  • 语种:English
  • 出版社:The National Academy of Sciences of the United States of America
  • 摘要:Suramin acts as a G protein inhibitor because it inhibits the rate-limiting step in activation of the G subunit, i.e., the exchange of GDP for GTP. Here, we have searched for analogues that are selective for Gs. Two compounds have been identified: NF449 (4,4',4",4'"-[carbonyl-bis[imino-5,1,3-benzenetriyl bis-(carbonylimino)]]tetrakis-(benzene-1,3-disulfonate) and NF503 (4,4'-[carbonylbis[imino-3,1-phenylene-(2,5-benzimidazolylene)carbonylimino]]bis-benzenesulfonate). These compounds (i) suppress the association rate of guanosine 5'-[{gamma}-thio]triphosphate ([35S]GTP[{gamma}S]) binding to Gs-s but not to Gi-1, (ii) inhibit stimulation of adenylyl cyclase activity in S49 cyc- membranes (deficient in endogenous Gs) by exogenously added Gs-s, and (iii) block the coupling of {beta}-adrenergic receptors to Gs with half-maximum effects in the low micromolar range. In contrast to suramin, which is not selective, NF503 and NF449 disrupt the interaction of the A1-adenosine receptor with its cognate G proteins (Gi/Go) at concentrations that are >30-fold higher than those required for uncoupling of {beta}-adrenergic receptor/Gs tandems; similarly, the angiotensin II type-1 receptor (a prototypical Gq-coupled receptor) is barely affected by the compounds. Thus, NF503 and NF449 fulfill essential criteria for Gs-selective antagonists. The observations demonstrate the feasibility of subtype-selective G protein inhibition.
国家哲学社会科学文献中心版权所有